|
|
| SPEAKER |
| Prof. Anthony Hollander |
| ARC Professor of Rheumatology & Tissue Engineering |
|
University Of Bristol
|
|
|
MEETING
|
|
December 2008 |
|
| BIOGRAPHY |
|
Professor Anthony Hollander is the Arthritis Research Campaign Professor of Rheumatology and Tissue Engineering at the University of Bristol. He graduated with a 1st in Pharmacology from the University of Bath and obtained his PhD in Pathology at The University of Bristol. After 3 years of postdoctoral work at McGill University in Canada and 7 years as a lecturer at Sheffield University, he took up his Chair at Bristol in September 2000. He has a group of 10 postdocs and PhD students, all working on stem cell and cartilage engineering projects. He has founded a spin-out company, Azellon Ltd, that is developing a stem cell therapy for torn meniscal cartilage and is leading pre-clinical in vivo trials of the menisical repair technique that will progress to the first clinical trial in 2009/2010.
|
| TALK |
|
Claudia's trachea: Lessons learned for future regenerative medicine strategies
|
| DESCRIPTION |
|
On June 12th 2008 the first tissue-engineered trachea, created using the patient's own cells and a decellularised donor trachea as scaffold, was implanted into Claudia Castillio's airway, thereby avoiding the need to remove her left lung and allowing her to lead a near normal life. Achieving this outcome required a strong scientific rationale, a determined and multidisciplinary team, flexible regulatory authorities, some risk-taking and a modicum of luck. Despite the best attempts of Easyjet to block the project the various pieces of a complex jigsaw came together at the right time and a little bit of history was made.
|
|
MEDIA
|
|
Audio
|
|
